Biotech Bankruptcies Face IP Challenges

Law360, New York (May 21, 2007, 12:00 AM EDT) -- Sticking a price tag on a life sciences or biotechnology company’s intellectual property can be a tall order, but the challenge becomes even greater when that company files for bankruptcy protection.

With an industry that often involves IP that is tied up in a developmental stage or that awaits federal approval, it is no wonder bankruptcy and IP attorneys have their work cut out for them in these types of bankruptcy cases.

“When taking a debtor through Chapter 11 while the company is in phase 3...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.